Using Mergent Online, summarize the differences between the results from your financial calculations of the most recent fiscal quarter and the results of the same financial calculations of the same fiscal quarter from a year before for Johnson and Johnson.(1st quarter 2022 and 1st quarter 2021).
- Explain what the results of your calculations and your comparison indicate about the businesss current financial health, providing examples to support your explanation.
- Do the results indicate the business is financially healthy or financially unhealthy? Which results indicate this?
- What might be the cause(s) of the businesss financial success or failure?
- Is more information needed to determine the businesss financial health? If so, which pieces of information might still be needed?
As Reported Quarterly Balance Sheet Report Date Currency Audit Status Consolidated Scale Cash & cash equivalents Marketable securities Accounts receivable, trade, gross Less allowances for doubtful accounts & credit losses Accounts receivable, trade Raw materials & supplies Goods in process Finished goods Inventories Prepaid expenses & other current assets Assets held for sale Total current assets Property, plant & equipment at cost Less: accumulated depreciation Property, plant & equipment, net Intangible assets, net Goodwill Deferred taxes on income Other assets Total assets Loans & notes payable Accounts payable Accrued liabilities Accrued rebates, returns & promotions Accrued compensation & employee related obligations 06/28/2020 09/27/2020 3rd Quarter 03/29/2020 1st Quarter 1st Quarter 3rd Quarter 2nd Quarter USD 04/03/2022 10/03/2021 07/04/2021 04/04/2021 1st Quarter USD USD Unaudited Unaudited Yes Yes Thousands Thousands 12,671,000 18,965,000 USD Unaudited 2nd Quarter USD Unaudited USD Unaudited USD Unaudited Unaudited Yes Yes Yes Yes Yes Thousands Thousands 11,174,000 15,530,000 11,948,000 11,816,000 7,961,000 2,494,000 Thousands Thousands Thousands 10,463,000 17,604,000 14,332,000 19,925,000 13,397,000 10,974,000 15,828,000 15,134,000 15,105,000 15,208,000 223,000 234,000 270,000 14,911,000 14,871,000 14,938,000 1,587,000 14,871,000 14,979,000 15,108,000 234,000 292,000 334,000 234,000 15,594,000 14,579,000 14,645,000 14,874,000 1,679,000 1,576,000 1,557,000 1,363,000 1,303,000 1,213,000 2,629,000 2,164,000 2,307,000 2,034,000 1,916,000 1,962,000 2,252,000 6,682,000 6,636,000 6,217,000 6,361,000 6,320,000 6,159,000 5,403,000 10,990,000 10,387,000 10,100,000 9,952,000 9,599,000 9,424,000 8,868,000 3,452,000 3,590,000 3,492,000 3,024,000 2,528,000 2,588,000 2,358,000 91,000 100,000 102,000 57,578,000 45,892,000 44,226,000 47,338,000 33,471,000 60,424,000 59,889,000 53,769,000 52,533,000 47,702,000 47,347,000 47,201,000 46,430,000 45,162,000 44,056,000 43,247,000 29,001,000 28,869,000 28,569,000 28,063,000 27,307,000 26,458,000 25,846,000 18,701,000 18,478,000 18,632,000 18,367,000 17,855,000 17,598,000 17,401,000 44,420,000 47,776,000 50,244,000 51,110,000 47,006,000 47,413,000 34,935,000 35,569,000 35,819,000 35,688,000 34,307,000 33,890,000 9,936,000 10,646,000 10,804,000 8,321,000 7,816,000 9,939,000 6,870,000 7,172,000 6,538,000 6,131,000 5,782,000 179,228,000 176,440,000 172,557,000 4,297,000 3,798,000 3,173,000 3,350,000 9,309,000 8,961,000 8,704,000 8,503,000 13,006,000 13,812,000 10,485,000 13,223,000 7,805,000 7,539,000 5,042,000 178,355,000 155,017,000 170,693,000 158,380,000 5,078,000 5,332,000 2,190,000 7,044,000 6,765,000 7,411,000 9,629,000 8,940,000 8,384,000 11,919,000 12,418,000 11,790,000 11,608,000 12,972,000 12,683,000 12,450,000 2,098,000 2,709,000 3,146,000 2,060,000 3,012,000 2,313,000 2,166,000 Accrued taxes on income Total current liabilities Notes Debentures Zero coupon convertible subordinated debentures Other long-term debt Long-term debt Deferred taxes on income Employee related obligations Long-term taxes payable Other liabilities Total liabilities Common stock Foreign currency translation Gain (loss) on securities Employee benefit plans Gain (loss) on derivatives & hedges Accumulated other comprehensive income (loss) Retained earnings (accumulated deficit) Less: common stock held in treasury, at cost Total shareholders' equity (deficit) 1,708,000 2,161,000 1,200,000 1,877,000 1,666,000 1,632,000 1,930,000 43,390,000 44,561,000 38,721,000 40,932,000 38,847,000 36,772,000 33,689,000 23,405,000 26,859,000 28,141,000 28,319,000 28,273,000 30,690,000 23,073,000 1,985,000 1,984,000 1,984,000 1,983,000 1,983,000 1,983,000 1,983,000 - 7,000 5,000 6,000 5,000 7,000 7,000 7,000 30,310,000 30,263,000 32,680,000 28,851,000 30,130,000 25,062,000 25,393,000 5,532,000 5,766,000 6,507,000 5,615,000 10,512,000 10,184,000 10,411,000 10,529,000 6,424,000 7,147,000 9,016,000 8,739,000 10,171,000 10,367,000 5,745,000 5,770,000 5,722,000 10,497,000 11,177,000 12,724,000 6,568,000 6,745,000 6,591,000 7,402,000 11,941,000 12,149,000 11,034,000 10,944,000 103,646,000 108,956,000 106,860,000 106,723,000 106,220,000 95,402,000 93,723,000 3,120,000 3,120,000 3,120,000 3,120,000 (10,571,000) (9,179,000) (8,797,000) (16,000) 3,120,000 (8,662,000) 3,120,000 3,120,000 (9,446,000) (9,668,000) (10,224,000) 1,000 2,000 (6,724,000) (6,696,000) (2,538,000) (6,257,000) (6,490,000) (632,000) 21,000 187,000 675,000 1,000 (6,304,000) (6,501,000) 57,000 811,000 636,000 (15,328,000) (14,938,000) (15,533,000) 116,508,000 114,831,000 113,898,000 38,540,000 38,507,000 65,834,000 64,473,000 62,978,000 (13,757,000) (15,415,000) (15,100,000) 124,380,000 121,092,000 120,154,000 39,034,000 (16,243,000) 112,901,000 38,484,000 74,709,000 70,272,000 69,580,000 61,294,000 38,525,000 38,594,000 38,466,000 As Reported Quarterly Income Statement Report Date Currency Audit Status Consolidated Scale Sales to customers Cost of products sold Gross profit (loss) Selling, marketing & administrative expenses Research & development expense In-process research & development expenses Interest income Interest expense, net of portion capitalized Other income (expense), net Restructuring expenses Earnings (loss) before provision for taxes on income Provision (benefit) for taxes on income Net earnings (loss) Weighted average shares outstanding - basic Weighted average shares outstanding - diluted Year end shares outstanding Net earnings (loss) per share - basic Net earnings (loss) per share - diluted Cash dividends per share 04/03/2022 10/03/2021 3rd Quarter 1st Quarter 2nd Quarter 1st Quarter USD Unaudited USD Unaudited Yes 07/04/2021 04/04/2021 09/27/2020 3rd Quarter USD Unaudited Yes USD Unaudited USD Unaudited Yes Thousands Thousands Yes Yes Thousands Thousands Thousands 23,426,000 23,338,000 23,312,000 22,321,000 7,598,000 7,250,000 15,828,000 16,088,000 5,938,000 6,000,000 3,462,000 3,422,000 610,000 900,000 22,000 13,000 10,000 20,000 102,000 (1,850,000) 70,000 60,000 5,862,000 3,849,000 713,000 182,000 5,149,000 3,667,000 2,629,200 2,632,600 2,666,500 2,674,900 2,629,384 2,632,485 1.96 1.39 1.93 1.37 1.06 1.06 06/28/2020 03/29/2020 2nd Quarter 1st Quarter USD Unaudited Yes USD Unaudited Yes Thousands Thousands 20,691,000 7,062,000 13,629,000 5,203,000 2,580,000 67,000 25,000 679,000 58,000 6,509,000 713,000 5,796,000 2,633,700 2,671,000 2,632,392 2.2 2.17 0.95 21,082,000 18,336,000 6,579,000 11,757,000 4,993,000 2,707,000 6,000 19,000 45,000 (24,000) 61,000 3,940,000 314,000 3,626,000 2,632,900 2,665,500 2,632,377 1.38 1.36 1.01 7,587,000 7,063,000 6,972,000 15,725,000 15,258,000 14,110,000 6,073,000 5,432,000 5,431,000 3,394,000 3,178,000 2,840,000 - 138,000 12,000 15,000 12,000 40,000 63,000 44,000 488,000 882,000 56,000 53,000 (1,200,000) 68,000 4,401,000 6,662,000 7,429,000 384,000 1,232,000 847,000 6,278,000 6,197,000 3,554,000 2,632,500 2,631,600 2,632,500 2,671,600 2,672,700 2,669,300 2,631,989 2,632,702 2,632,167 2.38 2.35 1.35 2.35 2.32 1.33 1.06 1.01 1.01 As Reported Quarterly Retained Earnings Report Date Currency Audit Status Consolidated Scale Previous retained earnings (accumulated deficit) Cumulative adjustment to retained earnings Cash dividends paid Employee compensation & stock option plans Other retained earnings (accumulated deficit) Retained earnings (accumulated deficit) 04/03/2022 1st Quarter USD Unaudited Yes Thousands 123,060,000 2,787,000 1,042,000 124,380,000 10/03/2021 3rd Quarter USD Unaudited Yes Thousands 120,154,000 2,791,000 (62,000) 121,092,000 07/04/2021 2nd Quarter USD Unaudited Yes Thousands 116,508,000 - 2,791,000 (159,000) 120,154,000 04/04/2021 1st Quarter USD Unaudited Yes Thousands 113,890,000 2,659,000 920,000 116,508,000 09/27/2020 3rd Quarter USD Unaudited Yes Thousands 113,898,000 2,659,000 (109,000) (71,000) 114,831,000 06/28/2020 2nd Quarter USD Unaudited Yes Thousands 112,901,000 2,659,000 (29,000) 1,000 113,898,000 03/29/2020 1st Quarter USD Unaudited Yes Thousands 110,659,000 2,505,000 1,049,000 112,901,000 As Reported Quarterly Cash Flow Report Date Currency Audit Status Consolidated Scale Net earnings (loss) Depreciation & amortization of property & intangibles Stock based compensation Asset write-downs Contingent consideration reversal Net loss (gain) on sale of assets Net loss (gain) on sale of assets or businesses Deferred tax provision (benefit) Credit losses & accounts receivable allowances Accounts receivable Inventories Accounts payable & accrued liabilities Other current & non-current assets Other current & non-current liabilities Net cash flows from operating activities Additions to property, plant & equipment Proceeds from the disposal of assets or businesses, net Acquisitions, net of cash acquired Purchases of investments Sales of investments Credit support agreements activity, net Other investing activities Other investing activities (primarily licenses & milestones) Net cash flows from investing activites 09/27/2020 04/03/2022 10/03/2021 07/04/2021 04/04/2021 1st Quarter 06/28/2020 03/29/2020 2nd 1st Quarter Quarter 3rd Quarter 2nd Quarter 1st Quarter 3rd Quarter USD USD USD USD USD Unaudited Unaudited Unaudited Unaudited Unaudited Yes Yes Yes Yes Yes Thousands Thousands Thousands Thousands Thousands 5,149,000 16,142,000 12,475,000 6,197,000 12,976,000 1,769,000 5,547,000 3,733,000 1,894,000 5,291,000 278,000 307,000 845,000 610,000 14,000 USD USD Unaudited Unaudited Yes Yes Thousands Thousands 9,422,000 5,796,000 3,473,000 1,747,000 589,000 920,000 964,000 661,000 26,000 198,000 263,000 33,000 11,000 (983,000) (983,000) (1,148,000) (60,000) (428,000) 54,000 117,000 22,000 (520,000) (812,000) (159,000) (168,000) (601,000) (601,000) (580,000) (60,000) (926,000) (2,564,000) (685,000) (730,000) (238,000) 6,000 (60,000) (52,000) (13,000) 74,000 (427,000) (1,818,000) (1,566,000) (1,604,000) (440,000) (600,000) (1,178,000) (818,000) (695,000) (784,000) (637,000) (2,817,000) 182,000 (4,050,000) (2,336,000) (119,000) (2,319,000) (2,523,000) 995,000 2,082,000 1,415,000 2,522,000 (1,983,000) (1,048,000) 271,000 110,000 (1,938,000) (1,150,000) (902,000) 581,000 (829,000) (329,000) 3,979,000 17,678,000 9,388,000 4,074,000 15,193,000 6,810,000 3,358,000 (607,000) (2,237,000) (1,490,000) (677,000) (2,024,000) (1,287,000) (625,000) 248,000 666,000 654,000 603,000 100,000 87,000 (252,000) (949,000) (949,000) (9,018,000) (18,843,000) (12,264,000) (5,994,000) (16,243,000) (8,551,000) (2,064,000) 6,303,000 16,809,000 12,453,000 5,233,000 6,585,000 2,417,000 1,544,000 672,000 17,000 (939,000) (249,000) 696,000 441,000 751,000 125,000 1,743,000 (257,000) (101,000) (516,000) (492,000) (59,000) (414,000) (398,000) (3,634,000) (3,323,000) (604,000) (185,000) (12,922,000) (8,103,000) (581,000) Other Net cash flows from investing activites Dividends to shareholders Repurchase of common stock Proceeds from short-term debt Repayment of short-term debt Proceeds from long-term debt, net of issuance costs Repayment of long-term debt Proceeds from the exercise of stock options or employee withholding tax on stock awards, net Credit support agreements activity, net Other financing activities Net cash flows from financing activities Effect of exchange rate changes on cash & cash equivalents Increase (decrease) in cash & cash equivalents Cash & cash equivalents, beginning of period Cash & cash equivalents, end of period investing activities (primarily licenses & milestones) (101,000) (516,000) (492,000) (59,000) (414,000) (398,000) (3,634,000) (3,323,000) (604,000) (185,000) (12,922,000) (8,103,000) (581,000) (2,787,000) (8,241,000) (5,450,000) (2,659,000) (7,823,000) (5,164,000) (2,505,000) (1,577,000) (2,460,000) (2,069,000) (1,438,000) (2,900,000) (2,417,000) (1,711,000) 3,335,000 2,717,000 (310,000) (17,000) 3,019,000 1,283,000 498,000 23,000 10,000 (856,000) (821,000) (689,000) (475,000) (18,000) 3,000 1,000 7,431,000 1,000 1,000 (2,132,000) (1,452,000) (1,451,000) (1,001,000) 321,000 808,000 543,000 236,000 (11,000) (562,000) (11,000) 922,000 708,000 332,000 (235,000) 168,000 212,000 (569,000) (489,000) (412,000) (476,000) (4,672,000) (4,315,000) 130,000 (138,000) 101,000 83,000 (24,000) (4,385,000) (10,611,000) (8,404,000) (5,125,000) 16,000 (125,000) (33,000) (78,000) (4,024,000) 3,619,000 347,000 (1,314,000) 14,487,000 13,985,000 13,985,000 13,985,000 17,305,000 10,463,000 17,604,000 14,332,000 12,671,000 18,965,000 (135,000) (166,000) (237,000) 1,660,000 (6,131,000) (1,775,000) 17,305,000 17,305,000 11,174,000 15,530,000 As Reported Quarterly Balance Sheet Report Date Currency Audit Status Consolidated Scale Cash & cash equivalents Marketable securities Accounts receivable, trade, gross Less allowances for doubtful accounts & credit losses Accounts receivable, trade Raw materials & supplies Goods in process Finished goods Inventories Prepaid expenses & other current assets Assets held for sale Total current assets Property, plant & equipment at cost Less: accumulated depreciation Property, plant & equipment, net Intangible assets, net Goodwill Deferred taxes on income Other assets Total assets Loans & notes payable Accounts payable Accrued liabilities Accrued rebates, returns & promotions Accrued compensation & employee related obligations 06/28/2020 09/27/2020 3rd Quarter 03/29/2020 1st Quarter 1st Quarter 3rd Quarter 2nd Quarter USD 04/03/2022 10/03/2021 07/04/2021 04/04/2021 1st Quarter USD USD Unaudited Unaudited Yes Yes Thousands Thousands 12,671,000 18,965,000 USD Unaudited 2nd Quarter USD Unaudited USD Unaudited USD Unaudited Unaudited Yes Yes Yes Yes Yes Thousands Thousands 11,174,000 15,530,000 11,948,000 11,816,000 7,961,000 2,494,000 Thousands Thousands Thousands 10,463,000 17,604,000 14,332,000 19,925,000 13,397,000 10,974,000 15,828,000 15,134,000 15,105,000 15,208,000 223,000 234,000 270,000 14,911,000 14,871,000 14,938,000 1,587,000 14,871,000 14,979,000 15,108,000 234,000 292,000 334,000 234,000 15,594,000 14,579,000 14,645,000 14,874,000 1,679,000 1,576,000 1,557,000 1,363,000 1,303,000 1,213,000 2,629,000 2,164,000 2,307,000 2,034,000 1,916,000 1,962,000 2,252,000 6,682,000 6,636,000 6,217,000 6,361,000 6,320,000 6,159,000 5,403,000 10,990,000 10,387,000 10,100,000 9,952,000 9,599,000 9,424,000 8,868,000 3,452,000 3,590,000 3,492,000 3,024,000 2,528,000 2,588,000 2,358,000 91,000 100,000 102,000 57,578,000 45,892,000 44,226,000 47,338,000 33,471,000 60,424,000 59,889,000 53,769,000 52,533,000 47,702,000 47,347,000 47,201,000 46,430,000 45,162,000 44,056,000 43,247,000 29,001,000 28,869,000 28,569,000 28,063,000 27,307,000 26,458,000 25,846,000 18,701,000 18,478,000 18,632,000 18,367,000 17,855,000 17,598,000 17,401,000 44,420,000 47,776,000 50,244,000 51,110,000 47,006,000 47,413,000 34,935,000 35,569,000 35,819,000 35,688,000 34,307,000 33,890,000 9,936,000 10,646,000 10,804,000 8,321,000 7,816,000 9,939,000 6,870,000 7,172,000 6,538,000 6,131,000 5,782,000 179,228,000 176,440,000 172,557,000 4,297,000 3,798,000 3,173,000 3,350,000 9,309,000 8,961,000 8,704,000 8,503,000 13,006,000 13,812,000 10,485,000 13,223,000 7,805,000 7,539,000 5,042,000 178,355,000 155,017,000 170,693,000 158,380,000 5,078,000 5,332,000 2,190,000 7,044,000 6,765,000 7,411,000 9,629,000 8,940,000 8,384,000 11,919,000 12,418,000 11,790,000 11,608,000 12,972,000 12,683,000 12,450,000 2,098,000 2,709,000 3,146,000 2,060,000 3,012,000 2,313,000 2,166,000 Accrued taxes on income Total current liabilities Notes Debentures Zero coupon convertible subordinated debentures Other long-term debt Long-term debt Deferred taxes on income Employee related obligations Long-term taxes payable Other liabilities Total liabilities Common stock Foreign currency translation Gain (loss) on securities Employee benefit plans Gain (loss) on derivatives & hedges Accumulated other comprehensive income (loss) Retained earnings (accumulated deficit) Less: common stock held in treasury, at cost Total shareholders' equity (deficit) 1,708,000 2,161,000 1,200,000 1,877,000 1,666,000 1,632,000 1,930,000 43,390,000 44,561,000 38,721,000 40,932,000 38,847,000 36,772,000 33,689,000 23,405,000 26,859,000 28,141,000 28,319,000 28,273,000 30,690,000 23,073,000 1,985,000 1,984,000 1,984,000 1,983,000 1,983,000 1,983,000 1,983,000 - 7,000 5,000 6,000 5,000 7,000 7,000 7,000 30,310,000 30,263,000 32,680,000 28,851,000 30,130,000 25,062,000 25,393,000 5,532,000 5,766,000 6,507,000 5,615,000 10,512,000 10,184,000 10,411,000 10,529,000 6,424,000 7,147,000 9,016,000 8,739,000 10,171,000 10,367,000 5,745,000 5,770,000 5,722,000 10,497,000 11,177,000 12,724,000 6,568,000 6,745,000 6,591,000 7,402,000 11,941,000 12,149,000 11,034,000 10,944,000 103,646,000 108,956,000 106,860,000 106,723,000 106,220,000 95,402,000 93,723,000 3,120,000 3,120,000 3,120,000 3,120,000 (10,571,000) (9,179,000) (8,797,000) (16,000) 3,120,000 (8,662,000) 3,120,000 3,120,000 (9,446,000) (9,668,000) (10,224,000) 1,000 2,000 (6,724,000) (6,696,000) (2,538,000) (6,257,000) (6,490,000) (632,000) 21,000 187,000 675,000 1,000 (6,304,000) (6,501,000) 57,000 811,000 636,000 (15,328,000) (14,938,000) (15,533,000) 116,508,000 114,831,000 113,898,000 38,540,000 38,507,000 65,834,000 64,473,000 62,978,000 (13,757,000) (15,415,000) (15,100,000) 124,380,000 121,092,000 120,154,000 39,034,000 (16,243,000) 112,901,000 38,484,000 74,709,000 70,272,000 69,580,000 61,294,000 38,525,000 38,594,000 38,466,000 As Reported Quarterly Income Statement Report Date Currency Audit Status Consolidated Scale Sales to customers Cost of products sold Gross profit (loss) Selling, marketing & administrative expenses Research & development expense In-process research & development expenses Interest income Interest expense, net of portion capitalized Other income (expense), net Restructuring expenses Earnings (loss) before provision for taxes on income Provision (benefit) for taxes on income Net earnings (loss) Weighted average shares outstanding - basic Weighted average shares outstanding - diluted Year end shares outstanding Net earnings (loss) per share - basic Net earnings (loss) per share - diluted Cash dividends per share 04/03/2022 10/03/2021 3rd Quarter 1st Quarter 2nd Quarter 1st Quarter USD Unaudited USD Unaudited Yes 07/04/2021 04/04/2021 09/27/2020 3rd Quarter USD Unaudited Yes USD Unaudited USD Unaudited Yes Thousands Thousands Yes Yes Thousands Thousands Thousands 23,426,000 23,338,000 23,312,000 22,321,000 7,598,000 7,250,000 15,828,000 16,088,000 5,938,000 6,000,000 3,462,000 3,422,000 610,000 900,000 22,000 13,000 10,000 20,000 102,000 (1,850,000) 70,000 60,000 5,862,000 3,849,000 713,000 182,000 5,149,000 3,667,000 2,629,200 2,632,600 2,666,500 2,674,900 2,629,384 2,632,485 1.96 1.39 1.93 1.37 1.06 1.06 06/28/2020 03/29/2020 2nd Quarter 1st Quarter USD Unaudited Yes USD Unaudited Yes Thousands Thousands 20,691,000 7,062,000 13,629,000 5,203,000 2,580,000 67,000 25,000 679,000 58,000 6,509,000 713,000 5,796,000 2,633,700 2,671,000 2,632,392 2.2 2.17 0.95 21,082,000 18,336,000 6,579,000 11,757,000 4,993,000 2,707,000 6,000 19,000 45,000 (24,000) 61,000 3,940,000 314,000 3,626,000 2,632,900 2,665,500 2,632,377 1.38 1.36 1.01 7,587,000 7,063,000 6,972,000 15,725,000 15,258,000 14,110,000 6,073,000 5,432,000 5,431,000 3,394,000 3,178,000 2,840,000 - 138,000 12,000 15,000 12,000 40,000 63,000 44,000 488,000 882,000 56,000 53,000 (1,200,000) 68,000 4,401,000 6,662,000 7,429,000 384,000 1,232,000 847,000 6,278,000 6,197,000 3,554,000 2,632,500 2,631,600 2,632,500 2,671,600 2,672,700 2,669,300 2,631,989 2,632,702 2,632,167 2.38 2.35 1.35 2.35 2.32 1.33 1.06 1.01 1.01 As Reported Quarterly Retained Earnings Report Date Currency Audit Status Consolidated Scale Previous retained earnings (accumulated deficit) Cumulative adjustment to retained earnings Cash dividends paid Employee compensation & stock option plans Other retained earnings (accumulated deficit) Retained earnings (accumulated deficit) 04/03/2022 1st Quarter USD Unaudited Yes Thousands 123,060,000 2,787,000 1,042,000 124,380,000 10/03/2021 3rd Quarter USD Unaudited Yes Thousands 120,154,000 2,791,000 (62,000) 121,092,000 07/04/2021 2nd Quarter USD Unaudited Yes Thousands 116,508,000 - 2,791,000 (159,000) 120,154,000 04/04/2021 1st Quarter USD Unaudited Yes Thousands 113,890,000 2,659,000 920,000 116,508,000 09/27/2020 3rd Quarter USD Unaudited Yes Thousands 113,898,000 2,659,000 (109,000) (71,000) 114,831,000 06/28/2020 2nd Quarter USD Unaudited Yes Thousands 112,901,000 2,659,000 (29,000) 1,000 113,898,000 03/29/2020 1st Quarter USD Unaudited Yes Thousands 110,659,000 2,505,000 1,049,000 112,901,000 As Reported Quarterly Cash Flow Report Date Currency Audit Status Consolidated Scale Net earnings (loss) Depreciation & amortization of property & intangibles Stock based compensation Asset write-downs Contingent consideration reversal Net loss (gain) on sale of assets Net loss (gain) on sale of assets or businesses Deferred tax provision (benefit) Credit losses & accounts receivable allowances Accounts receivable Inventories Accounts payable & accrued liabilities Other current & non-current assets Other current & non-current liabilities Net cash flows from operating activities Additions to property, plant & equipment Proceeds from the disposal of assets or businesses, net Acquisitions, net of cash acquired Purchases of investments Sales of investments Credit support agreements activity, net Other investing activities Other investing activities (primarily licenses & milestones) Net cash flows from investing activites 09/27/2020 04/03/2022 10/03/2021 07/04/2021 04/04/2021 1st Quarter 06/28/2020 03/29/2020 2nd 1st Quarter Quarter 3rd Quarter 2nd Quarter 1st Quarter 3rd Quarter USD USD USD USD USD Unaudited Unaudited Unaudited Unaudited Unaudited Yes Yes Yes Yes Yes Thousands Thousands Thousands Thousands Thousands 5,149,000 16,142,000 12,475,000 6,197,000 12,976,000 1,769,000 5,547,000 3,733,000 1,894,000 5,291,000 278,000 307,000 845,000 610,000 14,000 USD USD Unaudited Unaudited Yes Yes Thousands Thousands 9,422,000 5,796,000 3,473,000 1,747,000 589,000 920,000 964,000 661,000 26,000 198,000 263,000 33,000 11,000 (983,000) (983,000) (1,148,000) (60,000) (428,000) 54,000 117,000 22,000 (520,000) (812,000) (159,000) (168,000) (601,000) (601,000) (580,000) (60,000) (926,000) (2,564,000) (685,000) (730,000) (238,000) 6,000 (60,000) (52,000) (13,000) 74,000 (427,000) (1,818,000) (1,566,000) (1,604,000) (440,000) (600,000) (1,178,000) (818,000) (695,000) (784,000) (637,000) (2,817,000) 182,000 (4,050,000) (2,336,000) (119,000) (2,319,000) (2,523,000) 995,000 2,082,000 1,415,000 2,522,000 (1,983,000) (1,048,000) 271,000 110,000 (1,938,000) (1,150,000) (902,000) 581,000 (829,000) (329,000) 3,979,000 17,678,000 9,388,000 4,074,000 15,193,000 6,810,000 3,358,000 (607,000) (2,237,000) (1,490,000) (677,000) (2,024,000) (1,287,000) (625,000) 248,000 666,000 654,000 603,000 100,000 87,000 (252,000) (949,000) (949,000) (9,018,000) (18,843,000) (12,264,000) (5,994,000) (16,243,000) (8,551,000) (2,064,000) 6,303,000 16,809,000 12,453,000 5,233,000 6,585,000 2,417,000 1,544,000 672,000 17,000 (939,000) (249,000) 696,000 441,000 751,000 125,000 1,743,000 (257,000) (101,000) (516,000) (492,000) (59,000) (414,000) (398,000) (3,634,000) (3,323,000) (604,000) (185,000) (12,922,000) (8,103,000) (581,000) Other Net cash flows from investing activites Dividends to shareholders Repurchase of common stock Proceeds from short-term debt Repayment of short-term debt Proceeds from long-term debt, net of issuance costs Repayment of long-term debt Proceeds from the exercise of stock options or employee withholding tax on stock awards, net Credit support agreements activity, net Other financing activities Net cash flows from financing activities Effect of exchange rate changes on cash & cash equivalents Increase (decrease) in cash & cash equivalents Cash & cash equivalents, beginning of period Cash & cash equivalents, end of period investing activities (primarily licenses & milestones) (101,000) (516,000) (492,000) (59,000) (414,000) (398,000) (3,634,000) (3,323,000) (604,000) (185,000) (12,922,000) (8,103,000) (581,000) (2,787,000) (8,241,000) (5,450,000) (2,659,000) (7,823,000) (5,164,000) (2,505,000) (1,577,000) (2,460,000) (2,069,000) (1,438,000) (2,900,000) (2,417,000) (1,711,000) 3,335,000 2,717,000 (310,000) (17,000) 3,019,000 1,283,000 498,000 23,000 10,000 (856,000) (821,000) (689,000) (475,000) (18,000) 3,000 1,000 7,431,000 1,000 1,000 (2,132,000) (1,452,000) (1,451,000) (1,001,000) 321,000 808,000 543,000 236,000 (11,000) (562,000) (11,000) 922,000 708,000 332,000 (235,000) 168,000 212,000 (569,000) (489,000) (412,000) (476,000) (4,672,000) (4,315,000) 130,000 (138,000) 101,000 83,000 (24,000) (4,385,000) (10,611,000) (8,404,000) (5,125,000) 16,000 (125,000) (33,000) (78,000) (4,024,000) 3,619,000 347,000 (1,314,000) 14,487,000 13,985,000 13,985,000 13,985,000 17,305,000 10,463,000 17,604,000 14,332,000 12,671,000 18,965,000 (135,000) (166,000) (237,000) 1,660,000 (6,131,000) (1,775,000) 17,305,000 17,305,000 11,174,000 15,530,000
